Ardeparin Sodium
Generic Name: ardeparin sodium
Manufactured by PHARMACIA AND UPJOHN. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: ARDEPARIN SODIUM (10,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA020227.
Overview
Manufactured by PHARMACIA AND UPJOHN. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: ARDEPARIN SODIUM (10,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA020227.
Dosage
Available as injectable for injection use.
Related Medications
Triple Antibiotic Ointment
triple antibiotic ointment
Purpose Purpose First aid antibiotic First aid antibiotic First aid antibiotic
Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL). Category: BLA.
Clevidipine
clevidipine
Dihydropyridine Calcium Channel Blocker [EPC]
11 DESCRIPTION Cleviprex is a sterile, milky-white emulsion containing 0.5 mg/mL of clevidipine suitable for intravenous administration. Clevidipine is a dihydropyridine calcium channel blocker. Chemically, the active substance, clevidipine, is butyroxymethyl methyl 4-(2´,3´-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate. It is a racemic mixture with a molecular weight of 456.3 g/mol. Each enantiomer has equipotent antihypertensive activity.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.